CHOU-YI HSU

Prof. Dr. CHOU-YI HSU

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2025 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
Chou Yi HsuChou Yi Hsu
Chou Yi Hsu
SAshavan askar
shavan askar
SASamer Saleem Alshkarchy
Samer Saleem Alshkarchy
PNPriya Priyadarshini Nayak
Priya Priyadarshini Nayak
KAKassem alattabi
Kassem alattabi
HSHamed soleimani samarkhazan
Hamed soleimani samarkhazan
Cancer’s staggering molecular heterogeneity demands innovative approaches beyond traditional single-omics methods. The integration of multi-omics data, spanning genomics, transcriptomics, proteomics, metabolomics and radiomics, can improve diagnostic and prognostic accuracy when accompanied by rigorous preprocessing and external validation; for example, recent integrated classifiers report AUCs around 0.81–0.87 for difficult early-detection tasks. This review synthesizes how artificial intelligence (AI), particularly deep learning and machine learning, bridges this gap by enabling scalable, non-linear integration of disparate omics layers into clinically actionable insights. We explore cutting-edge AI methodologies, including graph neural networks for biological network modeling, transformers for cross-modal fusion, and explainable AI (XAI) for transparent clinical decision support. Critical applications are highlighted, such as AI-driven therapy selection (e.g., predicting targeted therapy resistance), proteogenomic early detection, and radiogenomic non-invasive diagnostics. We further address translational challenges: data harmonization, batch correction, missing data imputation, and computational scalability. Emerging trends, federated learning for privacy-preserving collaboration, spatial/single-cell omics for microenvironment decoding, quantum computing, and patient-centric “N-of-1” models, signal a paradigm shift toward dynamic, personalized cancer management. Despite persistent hurdles in model generalizability, ethical equity, and regulatory alignment, AI-powered multi-omics integration promises to transform precision oncology from reactive population-based approaches to proactive, individualized care.

8 December 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
NANoor Sabah Ahmed
Noor Sabah Ahmed
Chou Yi HsuChou Yi Hsu
Chou Yi Hsu
ZMZaid H. Mahmoud
Zaid H. Mahmoud
HSHamidreza Sayadi
Hamidreza Sayadi
EKEhsan Kianfar
Ehsan Kianfar
The level of free bilirubin is a considerable index for the characterization of jaundice-related diseases. Herein, a biosensor was fabricated via the immobilization of bilirubin oxidase (BOx) on graphene oxide (GO) and polyaniline (PANI) that were electrochemically co-precipitated on indium tin oxide (ITO) conductive glass. The structural enzyme electrode was characterized by FTIR, XRD, and Raman spectroscopy, while the spectral and thermal properties were investigated by UV-vis and thermogravimetric analysis (TGA). Owing to the activity of the fabricated BOx/GO@PANI/ITO biosensor, it could detect free bilirubin with good selectivity and sensitivity in a low response time. The electrochemical response was studied using electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). At polarization potential 0.2 V vs. Ag/AgCl, the fabricated sensor illustrated a response in only 2 s at 30 °C and pH 7.5. The LOD and LOQ for the BOx/GO@PANI/ITO biosensor were calculated and found to be 0.15 nM and 2.8 nM, respectively. The electrochemical signal showed a linear response in the concentration range 0.01–250 μM. At 5 °C, the biosensor demonstrated a half-time of 120 days, through which it could be utilized 100 times at this temperature conditions. By using a common colorimetric method, the data on bilirubin levels in serum showed a determination coefficient (R2) of 0.97.

23 May 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Chou Yi HsuChou Yi Hsu
Chou Yi Hsu
SJSaade Abdalkareem Jasim
Saade Abdalkareem Jasim
SASuaad Ahmed Saeed Hassen Aga
Suaad Ahmed Saeed Hassen Aga
KFKakul Hussin Firoz
Kakul Hussin Firoz
SJS. Renuka Jyothi
S. Renuka Jyothi
AHAlireza Hashemzadeh
Alireza Hashemzadeh

11 March 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
Chou Yi HsuChou Yi Hsu
Chou Yi Hsu
SRSadegh Rajabi
Sadegh Rajabi
MHMaryam Hamzeloo-Moghadam
Maryam Hamzeloo-Moghadam
AKAbhinav Kumar
Abhinav Kumar
Marc MarescaMarc Maresca
Marc Maresca
PGPallavi Ghildiyal
Pallavi Ghildiyal
Apoptosis is a programmed cell death comprising two signaling cascades including the intrinsic and extrinsic pathways. This process has been shown to be involved in the therapy response of different cancer types, making it an effective target for treating cancer. Cancer has been considered a challenging issue in global health. Cancer cells possess six biological characteristics during their developmental process known as cancer hallmarks. Hallmarks of cancer include continuous growth signals, unlimited proliferation, resistance to proliferation inhibitors, apoptosis escaping, active angiogenesis, and metastasis. Sesquiterpene lactones are one of the large and diverse groups of planet-derived phytochemicals that can be used as sources for a variety of drugs. Some sesquiterpene lactones possess many biological activities such as anti-inflammatory, anti-viral, anti-microbial, anti-malarial, anticancer, anti-diabetic, and analgesic. This review article briefly overviews the intrinsic and extrinsic pathways of apoptosis and the interactions between the modulators of both pathways. Also, the present review summarizes the potential effects of sesquiterpene lactones on different modulators of the intrinsic and extrinsic pathways of apoptosis in a variety of cancer cell lines and animal models. The main purpose of the present review is to give a clear picture of the current knowledge about the pro-apoptotic effects of sesquiterpene lactones on various cancers to provide future direction in cancer therapeutics.

24 January 2024 in Analytical Methods
Verified
Journal Article
Closed access
PDF file
Chou Yi HsuChou Yi Hsu
Chou Yi Hsu
RSRaed Obaid Saleh
Raed Obaid Saleh
HPHarikumar Pallathadka
Harikumar Pallathadka
AKAbhinav Kumar
Abhinav Kumar
SMSofiene Mansouri
Sofiene Mansouri
MHManar Mohammed Hizam
Manar Mohammed Hizam
Electrochemical techniques are commonly used to analyze and screen various environmental pathogens.

14 February 2025 in Nanoscale
Verified
Journal Article
Closed access
PDF file
Chou Yi HsuChou Yi Hsu
Chou Yi Hsu
NANusiba M. M. Alshik
Nusiba M. M. Alshik
IAIrfan Ahmad
Irfan Ahmad
SUSubasini Uthirapathy
Subasini Uthirapathy
SBSuhas Ballal
Suhas Ballal
KJKamal Kant Joshi
Kamal Kant Joshi
Utilization of MXene nanozymes in electrochemical and optical biosensors for food safety.